Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$1.16 - $2.74 $23,478 - $55,457
-20,240 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.62 - $5.43 $6,054 - $12,548
2,311 Added 12.89%
20,240 $53,000
Q2 2021

Aug 13, 2021

SELL
$5.06 - $8.15 $1,573 - $2,534
-311 Reduced 1.71%
17,929 $95,000
Q1 2021

May 14, 2021

SELL
$6.24 - $9.58 $152,412 - $233,991
-24,425 Reduced 57.25%
18,240 $123,000
Q4 2020

Feb 11, 2021

BUY
$6.28 - $8.79 $60,438 - $84,594
9,624 Added 29.13%
42,665 $289,000
Q3 2020

Nov 13, 2020

SELL
$7.5 - $11.11 $457 - $677
-61 Reduced 0.18%
33,041 $248,000
Q2 2020

Aug 14, 2020

BUY
$8.33 - $13.79 $275,739 - $456,476
33,102 New
33,102 $348,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.